If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse. Yes No Connect With Our Medical Experts Find My ViiV MSL Easily find the ViiV Medical Science Liaison (MSL) in your area. Request a Scie...
“Really understanding that quality of life– it's not a luxury. It's quite central to healthcare” PROF. GRAHAM BROWN Public Health Education & Policy Researcher in discussion with Brent Allan HIV Advocate PRO: patient-reported outcome. ...
At ViiV Healthcare we are dedicated to widening access to ensure those who need our medicines can receive them. Collaborations with organisations such as IAS, CHAI and MPP enable our medicines to make the greatest possible impact in countries around the world. As an example, our voluntary ...
ViiV Healthcare is a global leader focused on advancements in the research and the development of medicines for people living with HIV.
At ViiV Healthcare, we are driven by our mission to leave no person living with HIV or AIDS behind. As the only company solely focused on HIV and AIDS, we go beyond developing new medicines. We take a holistic approach to HIV and AIDS by developing and supporting sustainable community prog...
There will however be occasions when it may be in the interest of people living with HIV or those at high risk of acquiring HIV, to have access to our investigational medicines where enrolment into a clinical trial is not an option. Under these circumstances, and where people living with or...
access to anonymised patient-level clinical trial data and supporting clinical trial documents through the multi-sponsor data sharing portals. It is hoped that sharing these data with researchers will help to further scientific research, increase understanding of new and current medicines and ultimately ...
ViiV Healthcare's innovative portfolio of medicines provides options—because individualising care for people living with HIV matters, to you and to us. DOVATO (Dolutegravir/Lamivudine) Dovato (dolutegravir/lamivudine) is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infe...
ViiV Healthcare has submitted its once-monthly two-drug injected treatment for HIV to the US Food and Drug Administration (FDA).
Healthcare doesn’t exist in a vacuum That may sound obvious but delivering impactful initiatives that improve access to effective HIV medicines is a complex task. Finding the right price is a delicate balancing act if you are to effectively support health systems with their respective challenges ...